About the Journal

Peer Review Process

Manuscript (research article, review article, and case report) will be submitted by author to the editorial board. Manuscript is made either in English or Indonesian with abstracts written in English and Indonesian. The manuscript then be reviewed by the editorial board whether the manuscript will be process to review stage or put at waiting list for a temporary. Editorial board will review the format of the manuscript (submitted by the authors) whether it’s suit with the formatting of SCRIPTA SCORE Scientific Medical Journal (guideline is available) and plagiarism check. Manuscript indicated to plagiarism >20% will have to be re-worked or rejected if could not fulfil the requirement.

Manuscript passed this process will continue to double-blind peer-review process. The reviewer of the manuscript is someone who understands the main topic of the manuscript and able to give a relevant review to guide the editorial board in publishing the manuscript. The manuscript will be submitted to the reviewer for 2-4 weeks after the manuscript was submitted to the reviewer. The main concern of the reviewer is the scientific and ethical content of the manuscript. After the review completed, the result of the review can be submitted to the editorial board through the Open Journal System (OJS) by the reviewer itself.

After the manuscripts passed the review stage, reviewers' comment will be reviewed by the editorial board about the appropriateness and validity of the manuscript. The editorial board will state the editorial decision. The manuscript may be directly accepted, declined, or require revision. If the reviewer stated the manuscript is ready to be published without any revision, then the manuscript can directly enter the publishing phase immediately. Meanwhile, if the reviewer stated the manuscript needs some revisions by the author about the scientific content or ethical content, then the editorial board will return the manuscript and comments to the author to be revised according to the review of the reviewer.The recommended or type of the revision by the reviewer can be whether a major revisions or minor revisions depending on the review of the reviewer. Revised manuscript will be checked by the editorial board for tracking changes and reported to the reviewer, whether considered to be accepted or required further revision.

In the publishing phase, editorial board will summarize the manuscript that has been stated ready to publish by the reviewer in 1 volume consisting at least 10 manuscripts. The included manuscripts in 1 volume is summarized according to the internal discussion of the editorial board. The author of the manuscripts will be given a notification about the date and volume of publication and the hardcopy of SCRIPTA SCORE Scientific Medical Journal by an automated email by the Open Journal System. The publication will be done offline through the hardcopy/print-out copy of the SCRIPTA SCORE Scientific Medical Journal or done online by publication using website (talenta.usu.ac.id/scripta).

Open Access Policy

SCRIPTA SCORE Scientific Medical Journal provides immediate open access to its content with the intention of creating a condition where the medical and health knowledge freely available to the public and especially to fellow medical and health students in purpose of supporting a greater global exchange of knowledge.

Copyright

Authors retain copyright and grant SCRIPTA SCORE Scientific Medical Journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in SCRIPTA SCORE Scientific Medical Journal.

Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in SCRIPTA SCORE Scientific Medical Journal.

Content License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

You are free to:
Share — copy and redistribute the material in any medium or format

Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

NonCommercial — You may not use the material for commercial purposes.

No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.